Whole-body magnetic resonance angiography (MRA) found a surprisingly high prevalence of atherosclerosis in people considered at low to intermediate risk for cardiovascular disease, according to a study appearing online in the journal Radiology. Almost half of all study participants had at least one narrowed artery.

June 8, 2018 — Zebra Medical Vision unveiled its Textray chest X-ray research, which will form the basis for a future artificial intelligence (AI)-based automated chest X-ray analysis product the company is developing. Simultaneously, the company announced it has raised $30M in C round funding, bringing the total investment in the company to $50M.

IsoRay Inc. announced the upcoming release of its Build-Blu delivery system for real-time prostate brachytherapy.

A new report from the U.S. Food and Drug Administration (FDA) discusses the continued quality, safety and effectiveness of servicing of medical devices by original equipment manufacturers (OEMs) and third-party entities.

Konica Minolta Healthcare Americas Inc. announced the release of AeroRemote Insights, a cloud-based, business intelligence and analytics solution. AeroRemote Insights delivers detailed information on asset utilization, department workflow and efficiency, system health and more. The solution provides daily performance data in intuitive visual formats that managers can utilize to optimize department performance and manage digital radiography (DR) assets. This new service also enables managers to act on urgent situations immediately and respond to usage trends intelligently.

Philips announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Ingenia Elition 3.0T magnetic resonance imaging (MRI) solution and two clinical applications, Philips Compressed Sense and 3D APT. This integrated suite of innovations enables clinicians to perform exams up to 50 percent faster [1], increase diagnostic confidence and improve the patient experience.

A combination of digital mammography and tomosynthesis detects 90 percent more breast cancers than digital mammography alone, according to a study appearing online in the journal Radiology.[1]

June 5, 2018 — The U.S. Food and Drug Administration (FDA) has cleared the Biograph Vision, a new positron emission tomography/computed tomography (PET-CT) system from Siemens Healthineers. The system offers new technologies to help improve image quality with motion management, improved delineation and quantification of small lesions, and new detector technology.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now